Hernández-Andrade E, Ahued-Ahued JR

Language: Spanish
References: 11
Page: 492-496
PDF size: 81.17 Kb.

ABSTRACT

Objective. The aim of the present study was to evaluate transvaginal bleeding (TVB) as a risk factor for Rhesus is oimmunization during pregnancy, in order to optimize the application of Anti-D gammaglobulin in non-immunized pregnant women, as an alternative to the routine application of Anti-D at 28 weeks of gestation. Material and Methods. This case-control study was conducted from 1995 to 2001 at Mexico's National Perinatology Institute. Cases (n=24) were non-immunized pregnant women who showed positive anti-D antibody seroconversion during pregnancy or during the early puerperium. Controls (n=24) were non-immunized pregnant women who enrolled after each case, with similar clinical characteristics but who had no anti-D antibody seroconversion during pregnancy. In all cases the newborns were Rh-positive. None of the patients received immunoprofilaxis at 28 weeks of gestation.The presence of TVB was recorded at any stage of pregnancy and before labor. Odds ratios with 95% confidence intervals were used to assess associations. Results. TVB was observed in 18/24 (75%) cases and in 5/24 (20%) controls. Preterm uterine contractions and threatened miscarriage were the most frequent causes of TVB. The presence of one TVB event during pregnancy increased 11.4 times (95% CI 2.9-44.0) the likelihood of Rhesus isoimmunization. TVB after 20 weeks of gestation increased the likelihood 5.0 times (95%Cl 1.3-19.1). TVB before 20 weeks of gestation was not significantly associated with Rh isoimmunization (OR=7.6, 95%CI 0.8-69.5). Conclusions. Prophylaxis withanti-D gammaglobulin should be given to all non-immunized Rhesus-negative pregnant woman with TVB at any stage of pregnancy.

REFERENCES

1. Bowman J, Chown B, Lewis M, Pollock J. Rh isoimmunization during pregnancy: Antenatal prophylaxis. Can Med Assoc J 1978;1 18:623-627.

2. Trolle B. Prenatal Rh-Immune prophilaxis with 300 mg immune globulin anti-D in the 28th week of pregnancy. Acta Obstet Gynecol Stand 1989;68:45-47

3. Bowman J, Pollock J.Transplacental fetal hemorraghe after amniocentesis. Obstet Gynecol 1985;66:749-754.

4. Robson S, Lee D, Urbaniak S.Anti-D immunoglobulin in Rh-D prophilaxis. BJOG 1998;105:129-134.

5. Moise K. Management of Rhesus alloimunization in pregnancy. Obstet Gynecol 2002;100:600-611.

6. Ghosh S, Murphy W. Implementation of the Rhesus prevention programme:A prospective study. Scott Med J 1994;39:147-149.

7. Baptista-González H, Rosenfield-Mann F, Leis-Marquez T. Prevención de isoinmunización materna al RhD. con gama-globulina Anti-D. Salud Publica Mex 2001;43:52-58.

8. Jabara S, Barnhart T. Is Rh immune globulin needed in early first-trimester abortion? A review. Am J Obstet Gynecol 2003;188:623-627.

9. Bowman J, Pollock J. Rh immunization in Manitoba: Progress in prevention and treatment. Can Med Assoc J 1983;129:343-345.

10. Balderston K,Towers C, Rummey P, Montgomery D. Is the incidence of fetal-to-maternal hemorrhage increased in patients with third-trimester bleeding? Am J Obstet Gynecol 2003;188:1615-1621. II. Rose P, Strohm P, Zuspan F. Fetomaternal hemorrhage following trauma. Am J Obstet Gynecol 1985;153:844-847.

11. Weinberg L. Use of anti-D immunoglobulin in the treatment of threatened miscarriage in the accident and emergency department. Emerg Med J 2001;18:444-447.